Results 181 to 190 of about 4,205,927 (281)

Correction to: A process monitoring microreactor assembly for real-time reaction analysis using inline near-infrared spectroscopy and chemometrics. [PDF]

Anal Bioanal Chem
Mahler L, Desel P, Sladkov M, Roppertz A, Mayer C, Jaeger M.   +5 more
europepmc   +1 more source

A Survey on the Application of WirelessHART for Industrial Process Monitoring and Control. [PDF]

Sensors (Basel), 2021
Devan PAM, Hussin FA, Ibrahim R, Bingi K, Khanday FA.   +4 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

In-situ 3D temperature field modeling and characterization using eddy current for metal additive manufacturing process monitoring. [PDF]

Sci Rep
Peng L, Benavidez E, Mukherjee S, Morales RE, Tringe JW, Stobbe D, Deng Y.   +6 more
europepmc   +1 more source

Automated melt electrowritting platform with real-time process monitoring. [PDF]

HardwareX, 2021
Mieszczanek P, Eggert S, Corke P, Hutmacher DW.   +3 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Incorporation of doxorubicin into plant-derived nanovesicles: process monitoring and activity assessment. [PDF]

Drug Deliv
Steć A, Targońska M, Jaikishan S, Chen R, Mucha P, Czyrski GS, Jasiecki J, Płoska A, Heinz A, Wiedmer SK, Kalinowski L, Waleron K, Wielgomas B, Dziomba S.   +13 more
europepmc   +1 more source

Nonlinear Dynamic Process Monitoring Based on Ensemble Kernel Canonical Variate Analysis and Bayesian Inference. [PDF]

ACS Omega, 2022
Wang X, Wu P.
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

A process monitoring microreactor assembly for real-time reaction analysis using inline near-infrared spectroscopy and chemometrics. [PDF]

Anal Bioanal Chem
Mahler L, Desel P, Sladkov M, Roppertz A, Mayer C, Jaeger M.   +5 more
europepmc   +1 more source